Evidence map›Paper›PMID 40205234›Full record

ReviewMikrochimica acta2025

Innovations in graphene-based electrochemical biosensors in healthcare applications.

Sudenur Ozbey, Gulsu Keles, Sevinc Kurbanoglu

Abstract readReview
In one paragraph

Review in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sudenur OzbeyFaculty of Pharmacy, Department of Analytical Chemistry, Ankara University, 06560, Ankara, Türkiye.ORCID 0009-0002-3485-797X
Gulsu KelesFaculty of Pharmacy, Department of Analytical Chemistry, Ankara University, 06560, Ankara, Türkiye.ORCID 0009-0001-4630-4937
Sevinc KurbanogluFaculty of Pharmacy, Department of Analytical Chemistry, Ankara University, 06560, Ankara, Türkiye. skurbanoglu@gmail.com.ORCID 0000-0002-7079-7604

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The isolation of a single atomic layer of graphite, known as graphene, marked a fundamental moment that transformed the field of materials science. Graphene-based nanomaterials are recognized for their superior biocompatibility compared with many other types of nanomaterials. Moreover, one of the main reasons for the growing interest in graphene is its potential applications in emerging technologies. Its key characteristics, including high electrical conductivity, excellent intrinsic charge carrier mobility, optical transparency, substantial specific surface area, and remarkable mechanical flexibility, position it as an ideal candidate for applications in solar cells and touch screens. Its durability further establishes graphene as a strong contender for developing robust materials. To date, a variety of methods, such as traditional spectroscopic techniques and chromatographic approaches, have been developed for detecting biomolecules, drugs, and heavy metals. Electrochemical methods, known for their portability, selectivity, and impressive sensitivity, offer considerable convenience for both patients and professionals in point-of-care diagnostics. Recent advancements have significantly improved the capacity for rapid and accurate detection of analytes in trace amounts, providing substantial benefits in biosensor technology. Additionally, the integration of nanotechnology has markedly enhanced the sensitivity and selectivity of electrochemical sensors, yielding significantly improved results. Innovations such as point-of-care, lab-on-a-chip, implantable devices, and wearable sensors are discussed in this review.

Indexed as

Biosensing TechniquesElectrochemical TechniquesGraphiteHumansNanostructuresGraphiteElectrochemical sensorsGrapheneGraphiteLab-on-a-chipPoint of care diagnosisWearable sensors

Identifiers

PMID40205234
PMCPMC11982133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.